levodopa has been researched along with 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (52.94) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barzen, G; Cordes, M; Felix, R; Henkes, H; Hierholzer, J; Horowski, R; Keske, U; Poewe, W; Schelosky, L | 1 |
| Arnold, G; Gasser, T; Kirsch, CM; Oertel, WH; Schwarz, J; Tatsch, K; Trenkwalder, C | 1 |
| Angelberger, P; Brücke, T; Deecke, L; Küfferle, B; Müller, C; Podreka, I; Topitz, A; Wenger, S | 1 |
| Arnold, G; Gasser, T; Kirsch, CM; Oertel, WH; Schwarz, J; Tatsch, K | 1 |
| Battistin, L; Borsato, N; Briani, C; Chierichetti, F; Dam, M; Ferlin, G; Pizzolato, G; Rossato, A; Saitta, B; Zanco, P | 1 |
| Emrich, D; Hajak, G; Kögler, A; Munz, DL; Riemann, H; Rüther, E; Staedt, J; Stoppe, G | 1 |
| Battistin, L; Cagnin, A; Chierichetti, F; Dam, M; Fabbri, M; Ferlin, G; Pizzolato, G; Rossato, A | 1 |
| Oertel, WH; Schwarz, J; Tatsch, K | 1 |
| Arnold, G; Gasser, T; Oertel, WH; Schwarz, J; Tatsch, K | 1 |
| Eisensehr, I; Gildehaus, FJ; Linke, R; Noachtar, S; Tatsch, K; Trenkwalder, C; von Lindeiner, H; Wetter, TC | 1 |
| Hwang, WJ; Shen, LH; Ting, G; Wey, SP; Yao, WJ | 1 |
| Asenbaum, S; Auff, E; Bonelli, RM; Happe, S; Klösch, G; Mayer, K; Tribl, GG; Zeitlhofer, J | 1 |
| Colle, H; Temel, Y; van der Linden, C; Visser-Vandewalle, V | 1 |
| Hwang, WJ; Ting, G; Wey, SP; Yao, WJ | 1 |
| Alcaraz, R; Atarés, B; Bilbao, G; Garibi, J; Gómez-Esteban, JC; Lambarri, I; Lezcano, E; Zarranz, JJ | 1 |
| Costa, DC; Evans, AH; Gacinovic, S; Heales, S; Katzenschlager, R; Lee, P; Lees, AJ; O'sullivan, JD | 1 |
| Barthel, H; Hesse, S; Oehlwein, C; Polster, D; Sabri, O; Schwarz, J; Wagner, A | 1 |
3 trial(s) available for levodopa and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
| Article | Year |
|---|---|
Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).
Topics: Aged; Benzamides; Brain; Brain Chemistry; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Myoclonus; Polysomnography; Pyrrolidines; Receptors, Dopamine D2; Sleep Wake Disorders; Tomography, Emission-Computed, Single-Photon | 1995 |
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.
Topics: Adult; Aged; Apomorphine; Atrophy; Benzamides; Binding Sites; Cerebral Cortex; Dopamine; Dopamine Agonists; Dopamine Antagonists; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Predictive Value of Tests; Putamen; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1997 |
Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome.
Topics: Benzamides; Circadian Rhythm; Contrast Media; Corpus Striatum; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Restless Legs Syndrome; Tomography, Emission-Computed, Single-Photon | 2002 |
14 other study(ies) available for levodopa and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
| Article | Year |
|---|---|
[The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
Topics: Aged; Benzamides; Brain; Color; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Parkinson Disease; Protein Binding; Pyrrolidines; Receptors, Dopamine D2; Software; Tomography, Emission-Computed, Single-Photon | 1992 |
123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism.
Topics: Adult; Aged; Aged, 80 and over; Apomorphine; Benzamides; Humans; Iodine Radioisotopes; Levodopa; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine; Tomography, Emission-Computed, Single-Photon | 1992 |
Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
Topics: Adult; Aged; Aging; Antipsychotic Agents; Benzamides; Brain Diseases; Cerebellum; Corpus Striatum; Frontal Lobe; Humans; Huntington Disease; Iodine Radioisotopes; Levodopa; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1991 |
IBZM-SPECT as predictor for dopamimetic responsiveness of patients with de novo parkinsonian syndrome.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Apomorphine; Benzamides; Corpus Striatum; Dopamine D2 Receptor Antagonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Pyrrolidines; Receptors, Dopamine D1; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1993 |
Dopamine receptor SPET imaging in Parkinson's disease: a [123I]-IBZM and [99mTc]-HM-PAO study.
Topics: Adult; Aged; Basal Ganglia; Benzamides; Female; Humans; Levodopa; Male; Middle Aged; Organotechnetium Compounds; Oximes; Parkinson Disease; Pyrrolidines; Receptors, Dopamine; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1993 |
Alterations of striatal dopamine D2 receptors contribute to deteriorated response to L-dopa in Parkinson's disease: a [123I]-IBZM SPET study.
Topics: Adult; Aged; Antiparkinson Agents; Benzamides; Case-Control Studies; Corpus Striatum; Dopamine Agents; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1995 |
Iodine-123-iodobenzamide binding in parkinsonism: reduction by dopamine agonists but not L-Dopa.
Topics: Antiparkinson Agents; Benzamides; Brain; Case-Control Studies; Contrast Media; Dopamine Agonists; Dopamine Antagonists; Humans; Levodopa; Middle Aged; Parkinson Disease; Prospective Studies; Pyrrolidines; Time Factors; Tomography, Emission-Computed, Single-Photon | 1996 |
Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome.
Topics: Aged; Benzamides; Dopamine Agents; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Polysomnography; Pyrrolidines; Restless Legs Syndrome; Tomography, Emission-Computed, Single-Photon; Tropanes | 2001 |
Downregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation.
Topics: Adult; Aged; Benzamides; Corpus Striatum; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon | 2002 |
Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy--parkinsonism. Report of four cases.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Benzamides; Combined Modality Therapy; Contrast Media; Electric Stimulation Therapy; Female; Follow-Up Studies; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pyrrolidines; Subthalamic Nucleus; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2003 |
Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia.
Topics: Adult; Benzamides; Brain; Contrast Media; Diagnosis, Differential; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dystonia; Female; Humans; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Organotechnetium Compounds; Parkinsonian Disorders; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes | 2004 |
Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report.
Topics: Antiparkinson Agents; Benzamides; Dopamine Antagonists; Electric Stimulation Therapy; Follow-Up Studies; Humans; Immunohistochemistry; Levodopa; Male; Middle Aged; Multiple System Atrophy; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pyrrolidines; Retrospective Studies; Staining and Labeling; Subthalamic Nucleus; Synucleins; Tomography, Emission-Computed, Single-Photon | 2004 |
L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings.
Topics: Adult; Antiparkinson Agents; Benzamides; Brain; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease; Phenylketonurias; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes | 2004 |
Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome.
Topics: Aged; Antiparkinson Agents; Benzamides; Diagnosis, Differential; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Pyrrolidines; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tropanes | 2006 |